Nautilus Biotechnology

High-throughput, low-cost platform for analyzing and quantifying the human proteome

Contact us to add description.

Nautilus Biotechnology is unlocking the proteome to enable fundamental advances across human health and medicine. There is a wealth of information about human biology that is held within the proteome - the collection of proteins and their abundance in a cell. However, techniques to access this information have until now been limiting. Nautilus has created the first, large-scale, single-molecule platform to comprehensively quantify >95% of the proteome. The platform uses a protein array and fluorescent affinity-probes and was created by integrating innovations in computer science, engineering and biochemistry to deliver extreme sensitivity and scale. With this technology, biological research can lead to a better understanding of human diseases.

Jobs: